Reply: Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.

Boccara F, Rosenson RS, BEIJERINCK investigators

Open source

DOI
10.1016/j.jacc.2020.07.040
Published
2020 Sep 22
Container
Journal of the American College of Cardiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacc.2020.07.040,
  title = {Reply: Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.},
  author = {Boccara F and Rosenson RS and BEIJERINCK investigators},
  year = {2020},
  journal = {Journal of the American College of Cardiology},
  doi = {10.1016/j.jacc.2020.07.040},
  url = {https://doi.org/10.1016/j.jacc.2020.07.040}
}

RIS

TY  - JOUR
TI  - Reply: Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.
AU  - Boccara F
AU  - Rosenson RS
AU  - BEIJERINCK investigators
PY  - 2020
JO  - Journal of the American College of Cardiology
DO  - 10.1016/j.jacc.2020.07.040
UR  - https://doi.org/10.1016/j.jacc.2020.07.040
ER  - 

APA

F, B., RS, R., & investigators, B. (2020). Reply: Role of Ezetimibe in the Current Era in Treating Dyslipidemia in HIV-Infected Patients.. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2020.07.040

Source records